Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

November 3, 2020November 5, 2020

Two Small Trials Evaluating Focused Ultrasound in Treating Parkinson’s

News

Two small clinical trials are assessing MRI-guided focused ultrasound as a nonsurgical alternative for targeting the striatum — a brain region involved in voluntary movement control — to better ... Read more

October 29, 2020October 29, 2020

Holding to Mediterranean Diet Lowers Parkinson’s Risk for Women, Study Finds

News

Women who adhere closely to a Mediterranean diet in their 30s and 40s have a lower risk of Parkinson’s disease later in life, particularly once they reach their mid-60s, a large ... Read more

October 28, 2020October 28, 2020

Skin Samples May Aid Early Diagnosis of Parkinson’s, Study Suggests

News

A new method, originally developed to diagnose mad cow disease, shows effectiveness in measuring the buildup of alpha-synuclein in the skin of Parkinson’s disease patients, a new study reports. According ... Read more

October 27, 2020October 27, 2020

Non-invasive OpsisDx Diagnostic Test Awarded US Academy Research Grant

News

The Healthy Longevity Global Grand Challenge, founded by the U.S. National Academy of Medicine, has awarded a grant to develop Entopsis’ non-invasive, urine- and skin swab-based OpsisDx test for ... Read more

October 22, 2020October 22, 2020

Imbalance of Fat Content in Brain Cells May Fuel Parkinson’s Progression, Study Asserts

News

In patients with Parkinson’s disease, dopamine-producing neurons and microglia cells — the “immune cells” of the brain — accumulate fatty molecules that may promote inflammation and disease progression, a ... Read more

September 8, 2020September 8, 2020

New Software Tool Aids Early Diagnosis of Parkinson’s Disease Psychosis

News

PointClickCare has developed a new software tool to aid in the early diagnosis of Parkinson’s disease psychosis. The tool, developed in partnership with the American Society of Consultant Pharmacists (ASCP), is ... Read more

July 22, 2020July 24, 2020

FDA to Review Nuplazid as Treatment for Dementia-related Psychosis

News

The U.S. Food and Drug Administration (FDA) will review Acadia Pharmaceutical’s application asking that Nuplazid (pimavanserin) also be approved to treat hallucinations and delusions associated with various forms of dementia-related psychosis, ... Read more

July 17, 2020July 21, 2020

Phase 3 Trial Tests PhotoPharmics’ At-home Light Therapy to Ease Parkinson’s Symptoms

News

A new Phase 3 clinical trial will test PhotoPharmics‘ light-based, at-home therapy device — called Celeste — for Parkinson’s disease. The “Celeste Light for PD Trial” — a collaboration between ... Read more

July 10, 2020July 10, 2020

New Insight May Unveil Ways to Lessen Side Effects of Deep Brain Stimulation in Parkinson’s Patients

News

Distinct connections between nerve cells in the brain may explain why some Parkinson’s disease patients develop impulsivity and behavioral problems after deep brain stimulation (DBS) therapy, according to a ... Read more

July 9, 2020July 10, 2020

Deep Brain Stimulation Not Linked to Greater Risk of Dementia for Parkinson’s Patients, Study Concludes

News

Long-term deep brain stimulation (DBS) is cognitively safe and does not increase the risk for dementia in people with Parkinson’s disease, according to the results of a 10-year follow ... Read more